This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

SciClone Pharmaceuticals (SCLN)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 86.23M 85.80M 84.23M 66.65M
Receivables 40.27M 40.01M 38.11M 42.23M
Inventories 10.70M 15.24M 10.42M 8.81M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 140.20M 143.41M 137.33M 121.07M
Property, Plant & Equipment, Gross 5.18M 3.95M 3.90M 2.90M
Accumulated Depreciation & Depletion 3.33M 3.11M 2.53M 1.92M
Property, Plant & Equipment, Net 1.85M 843.00K 1.38M 984.00K
Intangibles 0.00 0.00 0.00 45.18M
Other Non-Current Assets 5.26M 242.00K 683.00K 1.11M
Total Non-Current Assets 41.63M 36.82M 36.74M 79.26M
Liabilities & Shareholder Equity
Total Assets 181.83M 180.23M 174.07M 200.33M
Accounts Payable 5.31M 7.19M 7.79M 5.59M
Short Term Debt 0.00 1.65M 1.44M 2.50M
Other Current Liabilities 0.00 5.03M 4.41M 3.27M
Total Current Liabilities 26.44M 33.59M 30.81M 25.28M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 8.72M
Other Non-Current Liabilities 114.00K 44.00K 237.00K 15.87M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 114.00K 44.00K 237.00K 24.58M
Total Liabilities 26.56M 33.63M 31.05M 49.87M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 155.27M 146.60M 143.02M 150.46M
Common Par 50.00K 52.00K 54.00K 58.00K
Additional Paid In Capital 287.11M 278.33M 274.39M 266.91M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -135.15M -135.96M -134.41M -118.85M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 3.26M 4.18M 2.99M 2.34M
Total Capitalization 155.27M 146.60M 143.02M 150.46M
Total Equity 155.27M 146.60M 143.02M 150.46M
Total Liabilities & Stock Equity 181.83M 180.23M 174.07M 200.33M
Total Common Shares Outstanding 49.95M 52.37M 54.48M 57.85M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 51.28M 53.59M 56.64M 55.11M
Diluted Weighted Shares Outstanding 52.68M 54.94M 58.48M 57.39M
Number of Employees 570 570 870 875
Number of Part-Time Employees 0 0 0 0
SCLN News

SCLN SciClone Pharmaceuticals

Analysts Ratings for SCLN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET SCLN ANALYST REPORT

Brokerage Partners

SCLN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs